BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 22294248)

  • 1. [Hematologic and immunologic signs of lupus: the experience of the hospital of Dakar].
    Ndiaye FS; Ka MM; Fall S; Dioum A; Pouye A; Moreira-Diop T
    Sante; 2011; 21(3):143-8. PubMed ID: 22294248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Frequency of hematological and immunological manifestations of lupus in Dakar].
    Ndiaye FS; Ndongo S; Fall S; Lèye Y; Dioum A; Ka MM; Moréira-Diop T
    Dakar Med; 2008; 53(3):192-7. PubMed ID: 19626790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current aspects of systemic lupus erythematosus in Dakar. About 74 cases].
    Fall S; Dia D; Ka EF; Diallo S; Pouye A; Kane A; Niang A; Dieng MT; Ka MM; Diouf B; Ndiaye B; Moreira DT
    Dakar Med; 2007; 52(3):160-4. PubMed ID: 19097395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and immunological manifestations of systemic lupus erythematosus: study on 146 south Tunisian patients.
    Jallouli M; Frigui M; Hmida MB; Marzouk S; Kaddour N; Bahloul Z
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):1001-8. PubMed ID: 18974596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Systemic lupus erythematosus in children with renal and hematologic manifestations. Relation to anti-nDNA antibodies].
    Martínez-Cordero E; Riebeling-Navarro CG; López-Zepeda J; Martínez-Miranda E; Negrete-García MC
    Bol Med Hosp Infant Mex; 1989 Jan; 46(1):11-21. PubMed ID: 2785391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Systemic lupus erythematosus in Lomé, Togo].
    Kombate K; Saka B; Oniankitan OI; Sodonougbo P; Mouhari-Toure A; Tchangai-Walla K; Pitche P
    Med Trop (Mars); 2008 Jun; 68(3):283-6. PubMed ID: 18689322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
    Faria AC; Barcellos KS; Andrade LE
    J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Profile of antinuclear antibodies in 14 cases of extinct systemic lupus erythematosus for more than 3 years].
    Meyer O; Molta C; Bourgeois P; Haim T; Kahn MF
    Rev Rhum Mal Osteoartic; 1990 Oct; 57(9):599-603. PubMed ID: 2075395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNase 1 activity in patients with systemic lupus erythematosus: relationship with epidemiological, clinical, immunological and therapeutical features.
    Martinez-Valle F; Balada E; Ordi-Ros J; Bujan-Rivas S; Sellas-Fernandez A; Vilardell-Tarres M
    Lupus; 2009 Apr; 18(5):418-23. PubMed ID: 19318394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus.
    Suleiman S; Kamaliah D; Nadeem A; Naing NN; Che Maraina CH
    Int J Rheum Dis; 2009 Jul; 12(2):100-6. PubMed ID: 20374326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characterization of a Portuguese population with systemic lupus erytematosus].
    Santos MJ; Capela S; Figueira R; Nero P; Matos AA; Silva C; Miranda L; Barcelos A; Marques A; Teixeira A; Branco J; da Silva JC; de Queiroz MV
    Acta Reumatol Port; 2007; 32(2):153-61. PubMed ID: 17576395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
    Pradhan VD; Patwardhan MM; Ghosh K
    Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic lupus erythematosus in Indian children.
    Ali US; Dalvi RB; Merchant RH; Mehta KP; Chablani AT; Badakere SS; Bhatia HM
    Indian Pediatr; 1989 Sep; 26(9):868-73. PubMed ID: 2634004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic lupus erythematosus in the Fars Province of Iran.
    Nazarinia MA; Ghaffarpasand F; Shamsdin A; Karimi AA; Abbasi N; Amiri A
    Lupus; 2008 Mar; 17(3):221-7. PubMed ID: 18372364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic lupus erythematosus: a clinical and immunological study of 300 patients].
    Font J; Pallarés L; Cervera R; Vivancos J; López-Soto A; Herrero C; Darnell A; Torras A; Mirapeix E; del Olmo JA
    Med Clin (Barc); 1993 Apr; 100(16):601-5. PubMed ID: 8497156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.
    Simón JA; Cabiedes J; Ortiz E; Alcocer-Varela J; Sánchez-Guerrero J
    Rheumatology (Oxford); 2004 Feb; 43(2):220-4. PubMed ID: 13130152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases.
    Ramos-Casals M; Nardi N; Brito-Zerón P; Aguiló S; Gil V; Delgado G; Bové A; Font J
    Semin Arthritis Rheum; 2006 Apr; 35(5):312-21. PubMed ID: 16616154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus.
    Hoffman IE; Peene I; Meheus L; Huizinga TW; Cebecauer L; Isenberg D; De Bosschere K; Hulstaert F; Veys EM; De Keyser F
    Ann Rheum Dis; 2004 Sep; 63(9):1155-8. PubMed ID: 15308527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lupus nephritis in Senegal: study of 42 cases].
    Dia D; Ka EF; Cissé M; Pouye A; Niang NM; Kane A; Dieng MT; Niang A; Ka MM; Diouf B; Ndiaye B; Moreira-Diop T
    Dakar Med; 2007; 52(1):23-6. PubMed ID: 19102087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?
    To CH; Petri M
    Arthritis Rheum; 2005 Dec; 52(12):4003-10. PubMed ID: 16320348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.